Q4 2015 EPS

1 stories · following the connections

Business

Esperion Therapeutics Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2015 Financial Results

By Nasdaq OMXFeb 25, 2016, 9:05 PM UTC